Somatic mutations affect key pathways in lung adenocarcinoma.
Ding L; Getz G; Wheeler DA; Mardis ER; McLellan MD; Cibulskis K; Sougnez C; Greulich H; Muzny DM; Morgan MB; Fulton L; Fulton RS; Zhang Q; Wendl MC; Lawrence MS; Larson DE; Chen K; Dooling DJ; Sabo A; Hawes AC; Shen H; Jhangiani SN; Lewis LR; Hall O; Zhu Y; Mathew T; Ren Y; Yao J; Scherer SE; Clerc K; Metcalf GA; Ng B; Milosavljevic A; Gonzalez-Garay ML; Osborne JR; Meyer R; Shi X; Tang Y; Koboldt DC; Lin L; Abbott R; Miner TL; Pohl C; Fewell G; Haipek C; Schmidt H; Dunford-Shore BH; Kraja A; Crosby SD; Sawyer CS; Vickery T; Sander S; Robinson J; Winckler W; Baldwin J; Chirieac LR; Dutt A; Fennell T; Hanna M; Johnson BE; Onofrio RC; Thomas RK; Tonon G; Weir BA; Zhao X; Ziaugra L; Zody MC; Giordano T; Orringer MB; Roth JA; Spitz MR; Wistuba II; Ozenberger B; Good PJ; Chang AC; Beer DG; Watson MA; Ladanyi M; Broderick S; Yoshizawa A; Travis WD; Pao W; Province MA; Weinstock GM; Varmus HE; Gabriel SB; Lander ES; Gibbs RA; Meyerson M; Wilson RK; Nature, 2008, vol. 455, issue 7216, p 1069, ISSN 14764687. ISBN 14764687.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef